In 2017, the United States, followed by (the leading 15 countries from) Western Europe, had that largest share of pharmaceutical revenue globally. For comparison, Australia had one of the lowest single shares among the listed countries. The data shows that the United States held 33 percent of global pharmaceutical revenue. The pharmaceutical industry is composed of various actors responsible for the discovery, development, and distribution of drugs and medicines.

The global pharma industry

The worldwide pharmaceutical market was recently valued at over 1.14 trillion U.S. dollars. Trends suggest that the pharmaceutical market globally is on the increase. In recent years Pfizer had the largest amount of global prescription sales; however, Roche had the highest research and development spending. Research and development is important for creating new, innovative pharmaceuticals, since branded products are under the threat of patent expiration and generic competition after a certain amount of years.

Leading therapeutic classes

Based on therapeutic classes, at this moment, the largest shares of pharmaceuticals sales globally are attributable to oncologics and pain management drugs. Among all therapeutic classes, Humira, Eliquis and Revlimid were the top three drugs sold. Among oncologics, the top pharmaceutical sales sector, Revlimid (marketed by Celgene) generated the most revenue in recent years.

This statistic depicts the estimated and forecasted annual revenues for various sectors of the health care industry worldwide in 2017 and 2018. For the medical technology industry a total global revenue of some were *** billion U.S. dollars was estimated in 2017. It was forecasted that it will increase up to *** billion U.S. dollars in 2018.

This statistic depicts the aggregated revenues worldwide of the ** leading Italian pharmaceutical companies from 2007 to 2017. According to data, the sector grew constantly over time. As a matter of fact, the aggregated earnings of the big players peaked in 2017 at ****** million euros.

In the first half of financial year 2019 Indian pharmaceutical companies saw an increase of **** percent in the net profit margins. This was a relief after a dip of *** percent in the first half of fiscal year 2018.

The revenue of Plx Pharma with headquarters in the United States amounted to *** million U.S. dollars in 2021. The reported fiscal year ends on December 31.Compared to the earliest depicted value from 2017 this is a total increase by approximately *** million U.S. dollars. The trend from 2017 to 2021 shows, however, that this increase did not happen continuously.

In the first half of financial year 2019, Indian pharmaceutical companies collectively had net sales worth approximately ** billion Indian rupees. This was an increase compared to the first half performance in fiscal year 2018 amounting to over ** billion rupees in net sales.

In 2023, Hanmi Pharmaceutical's consolidated net profit amounted to around *** billion South Korean won. This represents a major increase compared to the previous year, as well as the highest figure recorded since 2017.

The revenue change in the pharmaceuticals market in APAC was modeled to stand at **** percent in 2024. From 2017 to 2024, the revenue change rose by **** percentage points, though the increase followed an uneven trajectory rather than a consistent upward trend. Between 2024 and 2028, the revenue change will rise by **** percentage points, showing an overall upward trend with periodic ups and downs.Further information about the methodology, more market segments, and metrics can be found on the dedicated Market Insights page on Pharmaceuticals.

In 2022, the pharmaceutical industry in China generated total revenue of around ************* yuan, representing a slight year-on-year growth of ***************percent. Pharmaceutical preparations manufacturing and Chinese patent drug manufacturing are the biggest pharmaceutical segments in the country, while the significant sales of COVID-19 vaccines and the high profitability of traditional Chinese medicine products also contributed to the sector's substantial growth in 2021.

This statistic illustrates the market value at ex-factory prices of the pharmaceutical industry in Venezuela from 2008 to 2017, in billion U.S. dollars. In 2016, Venezuela's pharma industry generated a revenue of nearly **** billion U.S. dollars, same value registered a year earlier, but up from about **** billion in 2015.

This statistic shows the ranking of the top 20 companies of Ecuador's pharmaceutical retail market by revenue, as of 2017. Argentine company Roemmers takes the lead in the retail market with ***** million U.S. dollars, followed by Bayer and Sanofi. Ecuadorian company Medicamenta is to be found in the fourth place of the ranking.

This statistic shows the top ten pharmaceuticals companies worldwide based on anti-rheumatics revenue in 2017 and a projection for 2024. In 2017, Pfizer generated some *********** U.S. dollars in anti-rheumatics revenue and is expected to generate around the same revenue by 2022. Anti-rheumatic drugs are used to treat and slow the progress of rheumatoid arthritis. Rheumatoid arthritis is an autoimmune disease that principally attacks the joints but also impacts tissues and organs.

This statistic shows the 2025 ranking of the top 10 biotech and pharmaceutical companies worldwide, based on net income. U.S.-based company Johnson & Johnson was ranked first with a net income of **** billion U.S. dollars. Biotech and pharmaceutical companiesJohnson & Johnson and Merck & Co., both based in the United States, are among the world’s largest biotechnology and pharmaceutical companies based on their net incomes of approximately **** billion U.S. dollars and **** billion U.S. dollars, respectively, as of 2025. Johnson & Johnson generated some **** billion U.S. dollars of revenue in 2024. Pfizer had record-high annual revenues during the COVID-19 vaccination campaign, exceeding 100 billion U.S. dollars in 2022.

Story of a former blockbuster Lyrica was once one of Pfizer’s most successful products. It is an anticonvulsant for neuropathic pain and is also used as therapy for partial seizures. In the EU and in Russia, Lyrica has also been approved to treat general anxiety disorder. In 2017, this prescription medication generated some **** billion U.S. dollars in revenue.

The revenue change in the pharmaceuticals market in Indonesia was modeled to stand at **** percent in 2024. From 2017 to 2024, the revenue change rose by **** percentage points, though the increase followed an uneven trajectory rather than a consistent upward trend. Between 2024 and 2030, the revenue change will rise by **** percentage points, showing an overall upward trend with periodic ups and downs.Further information about the methodology, more market segments, and metrics can be found on the dedicated Market Insights page on Pharmaceuticals.

In 2017, the Brazilian pharmaceutical company Hypera Pharma generated a net revenue of approximately **** billion Brazilian reals, out of which ** percent corresponded to prescription products. Meanwhile, ** percent of the company's net revenue that year originated from biosimilar and generic medication.

The operating profit of Plx Pharma with headquarters in the United States amounted to ****** million U.S. dollars in 2021. The reported fiscal year ends on December 31.Compared to the earliest depicted value from 2017 this is a total decrease by approximately 24.94 million U.S. dollars. The trend from 2017 to 2021 shows, however, that this decrease did not happen continuously.

This statistic displays the gross value added in the pharmaceutical industry worldwide from 2006 to 2017. In 2017, the gross value added by the industry totaled 532 billion U.S. dollars. The pharmaceutical industry employs directly around 5.5 million people across the globe.

The revenue change in the pharmaceuticals market in Hungary was modeled to stand at **** percent in 2024. From 2017 to 2024, the revenue change rose by **** percentage points, though the increase followed an uneven trajectory rather than a consistent upward trend. Between 2024 and 2030, the revenue change will rise by **** percentage points, showing an overall upward trend with periodic ups and downs.Further information about the methodology, more market segments, and metrics can be found on the dedicated Market Insights page on Pharmaceuticals.

In 2023, Hanmi Pharmaceutical's sales amounted to around *** trillion South Korean won. This represents an increase from the previous year. The company contributed the majority of the total revenue including subsidiaries.

Commercial sales occupied the largest share of the pharmaceutical market in Russia, forecast to exceed *** trillion Russian rubles in 2025. The value of pharmaceuticals acquired via public procurement increased over the period under consideration, measuring at**** billion Russian rubles in 2024.